Pharmaceutical Benefits Scheme criteria for the use of tumour necrosis factor-α inhibitors in the treatment of ankylosing spondylitis in Australia: are they evidence based?

✍ Scribed by M. D. Smith; M. J. Ahern

• Book ID: 109001674
• Publisher: John Wiley and Sons
• Year: 2006
• Tongue: English
• Weight: 71 KB
• Volume: 36
• Category: Article
• ISSN: 1444-0903
• DOI: 10.1111/j.1445-5994.2006.01004.x